1 Bos, J. L. ras oncogenes in human cancer: a review. Cancer Res 49, 4682-4689 (1989).
2 Karnoub, A. E. & Weinberg, R. A. Ras oncogenes: split personalities. Nat Rev Mol Cell Biol 9, 517-531, doi:10.1038/nrm2438 (2008).
3 Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D. & Lowe, S. W. Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a. Cell 88, 593-602 (1997).
4 Lin, A. W. et al. Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling. Genes Dev 12, 3008-3019 (1998).
5 Campisi, J. Cellular senescence as a tumor-suppressor mechanism. Trends Cell Biol 11, S27-31 (2001).
6 Collado, M. et al. Tumour biology: senescence in premalignant tumours. Nature 436, 642, doi:10.1038/436642a (2005).
7 Martinez-Zamudio, R. I., Robinson, L., Roux, P. F. & Bischof, O. SnapShot: Cellular Senescence Pathways. Cell 170, 816-816 e811, doi:10.1016/j.cell.2017.07.049 (2017).
8 Fisher, G. H. et al. Induction and apoptotic regression of lung adenocarcinomas by regulation of a K-Ras transgene in the presence and absence of tumor suppressor genes. Genes Dev 15, 3249- 3262, doi:10.1101/gad.947701 (2001).
9 Johnson, L. et al. Somatic activation of the K-ras oncogene causes early onset lung cancer in mice.Nature 410, 1111-1116, doi:10.1038/35074129 (2001).
10 Voorhoeve, P. M. & Agami, R. The tumor-suppressive functions of the human INK4A locus.Cancer Cell 4, 311-319 (2003).
11 Wei, W., Jobling, W. A., Chen, W., Hahn, W. C. & Sedivy, J. M. Abolition of cyclin-dependent kinase inhibitor p16Ink4a and p21Cip1/Waf1 functions permits Ras-induced anchorage- independent growth in telomerase-immortalized human fibroblasts. Mol Cell Biol 23, 2859-2870 (2003).
12 Jackson, E. L. et al. The differential effects of mutant p53 alleles on advanced murine lung cancer.Cancer Res 65, 10280-10288, doi:10.1158/0008-5472.CAN-05-2193 (2005).
13 Hollstein, M., Sidransky, D., Vogelstein, B. & Harris, C. C. p53 mutations in human cancers.Science 253, 49-53 (1991).
14 Foulkes, W. D., Flanders, T. Y., Pollock, P. M. & Hayward, N. K. The CDKN2A (p16) gene and human cancer. Mol Med 3, 5-20 (1997).
15 Futreal, P. A. et al. A census of human cancer genes. Nat Rev Cancer 4, 177-183, doi:10.1038/nrc1299 (2004).
16 Burkhart, D. L. & Sage, J. Cellular mechanisms of tumour suppression by the retinoblastoma gene.Nat Rev Cancer 8, 671-682, doi:10.1038/nrc2399 (2008).
17 Fish, E. M. & Molitoris, B. A. Alterations in epithelial polarity and the pathogenesis of disease states. N Engl J Med 330, 1580-1588, doi:10.1056/NEJM199406023302207 (1994).
18 Martin-Belmonte, F. & Perez-Moreno, M. Epithelial cell polarity, stem cells and cancer. Nat Rev Cancer 12, 23-38, doi:10.1038/nrc3169 (2011).
19 Halaoui, R. & McCaffrey, L. Rewiring cell polarity signaling in cancer. Oncogene 34, 939-950, doi:10.1038/onc.2014.59 (2015).
20 Pagliarini, R. A. & Xu, T. A genetic screen in Drosophila for metastatic behavior. Science 302, 1227-1231, doi:10.1126/science.1088474 (2003).
21 Brumby, A. M. & Richardson, H. E. scribble mutants cooperate with oncogenic Ras or Notch to cause neoplastic overgrowth in Drosophila. EMBO J 22, 5769-5779, doi:10.1093/emboj/cdg548 (2003).
22 Yu, F. X., Zhao, B. & Guan, K. L. Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer. Cell 163, 811-828, doi:10.1016/j.cell.2015.10.044 (2015).
23 Zanconato, F., Cordenonsi, M. & Piccolo, S. YAP/TAZ at the Roots of Cancer. Cancer Cell 29, 783-803, doi:10.1016/j.ccell.2016.05.005 (2016).
24 Barry, E. R. et al. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493, 106-110, doi:10.1038/nature11693 (2013).
25 Slemmons, K. K., Crose, L. E., Rudzinski, E., Bentley, R. C. & Linardic, C. M. Role of the YAP Oncoprotein in Priming Ras-Driven Rhabdomyosarcoma. PLoS One 10, e0140781, doi:10.1371/journal.pone.0140781 (2015).
26 Zhang, W. et al. YAP promotes malignant progression of Lkb1-deficient lung adenocarcinoma through downstream regulation of survivin. Cancer Res 75, 4450-4457, doi:10.1158/0008- 5472.CAN-14-3396 (2015).
27 Lau, A. N. et al. Tumor-propagating cells and Yap/Taz activity contribute to lung tumor progression and metastasis. EMBO J 33, 468-481, doi:10.1002/embj.201386082 (2014).
28 Mohseni, M. et al. A genetic screen identifies an LKB1-MARK signalling axis controlling the Hippo-YAP pathway. Nat Cell Biol 16, 108-117, doi:10.1038/ncb2884 (2014).
29 Zhang, W. et al. Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci Signal 7, ra42, doi:10.1126/scisignal.2005049 (2014).
30 Nakamura, M., Ohsawa, S. & Igaki, T. Mitochondrial defects trigger proliferation of neighbouring cells via a senescence-associated secretory phenotype in Drosophila. Nat Commun 5, 5264, doi:10.1038/ncomms6264 (2014).
31 Wu, J. S. & Luo, L. A protocol for mosaic analysis with a repressible cell marker (MARCM) in Drosophila. Nat Protoc 1, 2583-2589, doi:10.1038/nprot.2006.320 (2006).
32 Potter, C. J. & Luo, L. Using the Q system in Drosophila melanogaster. Nat Protoc 6, 1105-1120,doi:10.1038/nprot.2011.347 (2011).
33 Xu, T. & Rubin, G. M. Analysis of genetic mosaics in developing and adult Drosophila tissues.Development 117, 1223-1237 (1993).
34 Heckman, K. L. & Pease, L. R. Gene splicing and mutagenesis by PCR-driven overlap extension.Nat Protoc 2, 924-932, doi:10.1038/nprot.2007.132 (2007).
35 Klambt, C. The Drosophila gene pointed encodes two ETS-like proteins which are involved in the development of the midline glial cells. Development 117, 163-176 (1993).
36 O'Neill, E. M., Rebay, I., Tjian, R. & Rubin, G. M. The activities of two Ets-related transcription factors required for Drosophila eye development are modulated by the Ras/MAPK pathway. Cell 78, 137-147 (1994).
37 Scholz, H., Deatrick, J., Klaes, A. & Klambt, C. Genetic dissection of pointed, a Drosophila gene encoding two ETS-related proteins. Genetics 135, 455-468 (1993).
38 Shwartz, A., Yogev, S., Schejter, E. D. & Shilo, B. Z. Sequential activation of ETS proteins provides a sustained transcriptional response to EGFR signaling. Development 140, 2746-2754, doi:10.1242/dev.093138 (2013).
39 Gabay, L. et al. EGF receptor signaling induces pointed P1 transcription and inactivates Yan protein in the Drosophila embryonic ventral ectoderm. Development 122, 3355-3362 (1996).
40 Lowe, S. W., Cepero, E. & Evan, G. Intrinsic tumour suppression. Nature 432, 307-315, doi:10.1038/nature03098 (2004).
41 Ohtani, N. et al. Opposing effects of Ets and Id proteins on p16INK4a expression during cellular senescence. Nature 409, 1067-1070, doi:10.1038/35059131 (2001).
42 Huot, T. J. et al. Biallelic mutations in p16(INK4a) confer resistance to Ras- and Ets-induced senescence in human diploid fibroblasts. Mol Cell Biol 22, 8135-8143 (2002).
43 O'Hara, S. P. et al. ETS Proto-oncogene 1 Transcriptionally Up-regulates the Cholangiocyte Senescence-associated Protein Cyclin-dependent Kinase Inhibitor 2A. J Biol Chem 292, 4833- 4846, doi:10.1074/jbc.M117.777409 (2017).
44 Macleod, K. F. et al. p53-dependent and independent expression of p21 during cell growth, differentiation, and DNA damage. Genes Dev 9, 935-944 (1995).
45 Beier, F., Taylor, A. C. & LuValle, P. The Raf-1/MEK/ERK pathway regulates the expression of the p21(Cip1/Waf1) gene in chondrocytes. J Biol Chem 274, 30273-30279 (1999).
46 Park, J. S. et al. A role for both Ets and C/EBP transcription factors and mRNA stabilization in the MAPK-dependent increase in p21 (Cip-1/WAF1/mda6) protein levels in primary hepatocytes. Mol Biol Cell 11, 2915-2932, doi:10.1091/mbc.11.9.2915 (2000).
47 Park, U. S., Park, S. K., Lee, Y. I., Park, J. G. & Lee, Y. I. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells. Oncogene 19, 3384-3394, doi:10.1038/sj.onc.1203674 (2000).
48 Doura, T. et al. Detection of LacZ-Positive Cells in Living Tissue with Single-Cell Resolution.Angew Chem Int Ed Engl 55, 9620-9624, doi:10.1002/anie.201603328 (2016).
49 Dimri, G. P. et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 92, 9363-9367 (1995).
50 Lee, B. Y. et al. Senescence-associated beta-galactosidase is lysosomal beta-galactosidase. Aging Cell 5, 187-195, doi:10.1111/j.1474-9726.2006.00199.x (2006).
51 Zielke, N. et al. Fly-FUCCI: A versatile tool for studying cell proliferation in complex tissues.Cell Rep 7, 588-598, doi:10.1016/j.celrep.2014.03.020 (2014).
52 Baker, N. E. Cell proliferation, survival, and death in the Drosophila eye. Semin Cell Dev Biol 12, 499-507, doi:10.1006/scdb.2001.0274 (2001).
53 Narita, M. et al. Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence. Cell 113, 703-716 (2003).
54 Narita, M. et al. A novel role for high-mobility group a proteins in cellular senescence and heterochromatin formation. Cell 126, 503-514, doi:10.1016/j.cell.2006.05.052 (2006).
55 Igaki, T., Pagliarini, R. A. & Xu, T. Loss of cell polarity drives tumor growth and invasion through JNK activation in Drosophila. Curr Biol 16, 1139-1146, doi:10.1016/j.cub.2006.04.042 (2006).
56 Enomoto, M. & Igaki, T. Deciphering tumor-suppressor signaling in flies: genetic link between Scribble/Dlg/Lgl and the Hippo pathways. J Genet Genomics 38, 461-470, doi:10.1016/j.jgg.2011.09.005 (2011).
57 Menendez, J., Perez-Garijo, A., Calleja, M. & Morata, G. A tumor-suppressing mechanism in Drosophila involving cell competition and the Hippo pathway. Proc Natl Acad Sci U S A 107, 14651-14656, doi:10.1073/pnas.1009376107 (2010).
58 Yamamoto, M., Ohsawa, S., Kunimasa, K. & Igaki, T. The ligand Sas and its receptor PTP10D drive tumour-suppressive cell competition. Nature 542, 246-250, doi:10.1038/nature21033 (2017).
59 Brennecke, J., Hipfner, D. R., Stark, A., Russell, R. B. & Cohen, S. M. bantam encodes a developmentally regulated microRNA that controls cell proliferation and regulates the proapoptotic gene hid in Drosophila. Cell 113, 25-36 (2003).
60 Nolo, R., Morrison, C. M., Tao, C., Zhang, X. & Halder, G. The bantam microRNA is a target of the hippo tumor-suppressor pathway. Curr Biol 16, 1895-1904, doi:10.1016/j.cub.2006.08.057 (2006).
61 Thompson, B. J. & Cohen, S. M. The Hippo pathway regulates the bantam microRNA to control cell proliferation and apoptosis in Drosophila. Cell 126, 767-774, doi:10.1016/j.cell.2006.07.013 (2006).
62 Jonas, S. & Izaurralde, E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 16, 421-433, doi:10.1038/nrg3965 (2015).
63 Betel, D., Wilson, M., Gabow, A., Marks, D. S. & Sander, C. The microRNA.org resource: targets and expression. Nucleic Acids Res 36, D149-153, doi:10.1093/nar/gkm995 (2008).
64 Kruger, J. & Rehmsmeier, M. RNAhybrid: microRNA target prediction easy, fast and flexible.Nucleic Acids Res 34, W451-454, doi:10.1093/nar/gkl243 (2006).
65 Ruby, J. G. et al. Evolution, biogenesis, expression, and target predictions of a substantially expanded set of Drosophila microRNAs. Genome Res 17, 1850-1864, doi:10.1101/gr.6597907 (2007).
66 Huang, H. & Tindall, D. J. Dynamic FoxO transcription factors. J Cell Sci 120, 2479-2487, doi:10.1242/jcs.001222 (2007).
67 Eyers, P. A., Keeshan, K. & Kannan, N. Tribbles in the 21st Century: The Evolving Roles of Tribbles Pseudokinases in Biology and Disease. Trends Cell Biol 27, 284-298, doi:10.1016/j.tcb.2016.11.002 (2017).
68 Gerlach, S. U., Sander, M., Song, S. & Herranz, H. The miRNA bantam regulates growth and tumorigenesis by repressing the cell cycle regulator tribbles. Life Sci Alliance 2, doi:10.26508/lsa.201900381 (2019).
69 Hedrick, S. M., Hess Michelini, R., Doedens, A. L., Goldrath, A. W. & Stone, E. L. FOXO transcription factors throughout T cell biology. Nat Rev Immunol 12, 649-661, doi:10.1038/nri3278 (2012).
70 Xie, Q. et al. YAP/TEAD-mediated transcription controls cellular senescence. Cancer Res 73, 3615-3624, doi:10.1158/0008-5472.CAN-12-3793 (2013).
71 Zanella, F. et al. Human TRIB2 is a repressor of FOXO that contributes to the malignant phenotype of melanoma cells. Oncogene 29, 2973-2982, doi:10.1038/onc.2010.58 (2010).
72 Nogueira, V. et al. Akt determines replicative senescence and oxidative or oncogenic premature senescence and sensitizes cells to oxidative apoptosis. Cancer Cell 14, 458-470, doi:10.1016/j.ccr.2008.11.003 (2008).
73 Zheng, L. et al. microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS One 8, e55719, doi:10.1371/journal.pone.0055719 (2013).
74 Lefter, L. P. et al. Transcriptional silencing of ETS-1 efficiently suppresses angiogenesis of pancreatic cancer. Cancer Gene Ther 16, 137-148, doi:10.1038/cgt.2008.65 (2009).
75 Ito, T. et al. Expression of the ets-1 proto-oncogene in human pancreatic carcinoma. Mod Pathol 11, 209-215 (1998).
76 Zhu, L. et al. MicroRNA-9 up-regulation is involved in colorectal cancer metastasis via promoting cell motility. Med Oncol 29, 1037-1043, doi:10.1007/s12032-011-9975-z (2012).
77 Zhang, Y. et al. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 33, 698-709, doi:10.1007/s00268-008-9833-0 (2009).
78 Cai, L. & Cai, X. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma. Diagn Pathol 9, 1000, doi:10.1186/s13000-014-0228-2 (2014).
79 Gwak, J. M. et al. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer. Breast Cancer Res Treat 147, 39-49, doi:10.1007/s10549-014-3069-5 (2014).
80 Xu, T. et al. Up-regulation of miR-9 expression as a poor prognostic biomarker in patients with non-small cell lung cancer. Clin Transl Oncol 16, 469-475, doi:10.1007/s12094-013-1106-1 (2014).
81 Chen, X. et al. Oncogenic miR-9 is a target of erlotinib in NSCLCs. Sci Rep 5, 17031, doi:10.1038/srep17031 (2015).
82 Azizmohammadi, S. et al. Molecular identification of miR-145 and miR-9 expression level as prognostic biomarkers for early-stage cervical cancer detection. QJM 110, 11-15, doi:10.1093/qjmed/hcw101 (2017).
83 Baker, D. J. et al. Naturally occurring p16(Ink4a)-positive cells shorten healthy lifespan. Nature 530, 184-189, doi:10.1038/nature16932 (2016).
84 Baker, D. J. et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479, 232-236, doi:10.1038/nature10600 (2011).
85 He, S. & Sharpless, N. E. Senescence in Health and Disease. Cell 169, 1000-1011, doi:10.1016/j.cell.2017.05.015 (2017).
86 Alic, N. et al. Interplay of dFOXO and two ETS-family transcription factors determines lifespan in Drosophila melanogaster. PLoS Genet 10, e1004619, doi:10.1371/journal.pgen.1004619 (2014).
87 Dobson, A. J. et al. Longevity is determined by ETS transcription factors in multiple tissues and diverse species. PLoS Genet 15, e1008212, doi:10.1371/journal.pgen.1008212 (2019).
88 Slack, C. et al. The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity. Cell 162, 72- 83, doi:10.1016/j.cell.2015.06.023 (2015).
89 Fontana, L., Partridge, L. & Longo, V. D. Extending healthy life span--from yeast to humans.Science 328, 321-326, doi:10.1126/science.1172539 (2010).
90 Martins, R., Lithgow, G. J. & Link, W. Long live FOXO: unraveling the role of FOXO proteins in aging and longevity. Aging Cell 15, 196-207, doi:10.1111/acel.12427 (2016).
91 Postnikoff, S. D., Malo, M. E., Wong, B. & Harkness, T. A. The yeast forkhead transcription factors fkh1 and fkh2 regulate lifespan and stress response together with the anaphase-promoting complex. PLoS Genet 8, e1002583, doi:10.1371/journal.pgen.1002583 (2012).
92 Willcox, B. J. et al. FOXO3A genotype is strongly associated with human longevity. Proc Natl Acad Sci U S A 105, 13987-13992, doi:10.1073/pnas.0801030105 (2008).
93 Ristow, M. Unraveling the truth about antioxidants: mitohormesis explains ROS-induced health benefits. Nat Med 20, 709-711, doi:10.1038/nm.3624 (2014).
論文の公開元へ
